Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress
- 1 May 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 294 (5), H2197-H2203
- https://doi.org/10.1152/ajpheart.91496.2007
Abstract
Intermittent hypoxia due to sleep apnea syndrome is associated with cardiovascular diseases. However, the precise mechanisms by which intermittent hypoxic stress accelerates cardiovascular diseases are largely unclear. The aim of this study was to investigate the role of gp91 phox-containing NADPH oxidase in the development of left ventricular (LV) remodeling induced by intermittent hypoxic stress in mice. Male gp91 phox-deficient (gp91−/−) mice ( n = 26) and wild-type ( n = 39) mice at 7–12 wk of age were exposed to intermittent hypoxia (30 s of 4.5–5.5% O2 followed by 30 s of 21% O2 for 8 h/day during daytime) or normoxia for 10 days. Mean blood pressure and LV systolic and diastolic function were not changed by intermittent hypoxia in wild-type or gp91−/− mice, although right ventricular systolic pressure tended to be increased. In wild-type mice, intermittent hypoxic stress significantly increased the diameter of cardiomyocytes and interstitial fibrosis in LV myocardium. Furthermore, intermittent hypoxic stress increased superoxide production, 4-hydroxy-2-nonenal protein, TNF-α and transforming growth factor-β mRNA, and NF-κB binding activity in wild-type, but not gp91−/−, mice. These results suggest that gp91 phox-containing NADPH oxidase plays a crucial role in the pathophysiology of intermittent hypoxia-induced LV remodeling through an increase of oxidative stress.Keywords
This publication has 36 references indexed in Scilit:
- Angiotensin II Receptor Blocker Reduces Oxidative Stress and Attenuates Hypoxia-Induced Left Ventricular Remodeling in Apolipoprotein E-Knockout MiceHypertension Research, 2007
- Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarctionEuropean Heart Journal, 2006
- NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failureCardiovascular Research, 2006
- Requirement of Rac1 in the development of cardiac hypertrophyProceedings of the National Academy of Sciences, 2006
- Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox)American Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Chronic intermittent hypoxia increases infarction in the isolated rat heartJournal of Applied Physiology, 2005
- NF-κB activation is required for the development of cardiac hypertrophy in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathyPublished by Oxford University Press (OUP) ,2000
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Ultrastructure and immunohistochemistry of the coronary chemoreceptor in human and canine heartsAmerican Heart Journal, 1995